Marina Biotech Announces Name Change to Adhera Therapeutics to More Closely Reflect the Mission of Improving Patient Outcomes
09 oct. 2018 08h00 HE
|
Marina Biotech, Inc.
Research Triangle Park, NC, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Marina Biotech, Inc. (OTCQB: MRNA), a commercial stage pharmaceutical company focused on the development and commercialization of...
Marina Biotech Appoints Nancy R. Phelan to the Board of Directors
03 oct. 2018 08h00 HE
|
Marina Biotech, Inc.
Research Triangle Park, NC, Oct. 03, 2018 (GLOBE NEWSWIRE) -- Marina Biotech, Inc. (OTCQB: MRNA), a commercial stage pharmaceutical company focused on the development and commercialization of...
Marina Biotech Appoints Uli Hacksell, Ph.D. and Robert C. Moscato to Board of Directors
29 juin 2018 09h15 HE
|
Marina Biotech, Inc.
City of Industry, CA, June 29, 2018 (GLOBE NEWSWIRE) -- Marina Biotech, Inc. (OTCQB: MRNA), a commercial stage pharmaceutical company focused on the development and commercialization of innovative...
Marina Biotech Appoints Robert Moscato to Chief Executive Officer
20 juin 2018 11h30 HE
|
Marina Biotech, Inc.
City of Industry, CA, June 20, 2018 (GLOBE NEWSWIRE) -- Marina Biotech, Inc. (OTCQB: MRNA), a commercial stage pharmaceutical company focused on the development and commercialization of innovative...